Scientists probe Fat-Immune link in rare and common metabolic diseases

NCT ID NCT01784289

Completed Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 126 people with different fat distribution patterns—including those with lipodystrophy (abnormal fat loss or distribution), obesity, and normal weight—to understand how fat tissue relates to insulin resistance and immune signals. Researchers measured blood levels of interleukin-7 and other immune markers, along with fat mass using scans. The goal was to gather knowledge, not to test a treatment, so no direct benefit for participants was expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPODYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lipodystrophy Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIPODYSTROPHY OBESITY TYPE 2 DIABETES

Contacts and locations

Locations

Amiens University Hospital

Amiens, 80054, France
Caen University Hospital

Caen, 14032, France
Lille University Hospital

Lille, 59037, France
Reims University Hospital

Reims, 51092, France
Rouen University Hospital

Rouen, 76031, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.